Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
418.18%Stock Based Compensation Margin
VS
Market
Sector
Industry
History
$ 1.39Close
$ 0.68 - $ 3.23 52-Week Range
Ticker Information
Ticker
FATECompany Name
FATE THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQFATE THERAPEUTICS INC - Stock Based Compensation Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
FATE - SB Comp % Historical data
| Date | Revenues | Stock Based Compensation | Stock Based Compensation Margin |
|---|---|---|---|
| 6/30/2025 | $ 8.47M | $ 35.42M | 418.18% |
| 3/31/2025 | $ 13.34M | $ 37.9M | 284.18% |
| 12/31/2024 | $ 13.63M | $ 41.5M | 304.42% |
| 9/30/2024 | $ 13.45M | $ 41.85M | 311.23% |
| 6/30/2024 | $ 12.32M | $ 40.19M | 326.3% |
| 3/31/2024 | $ 6.48M | $ 43.46M | 670.84% |
| 12/31/2023 | $ 63.53M | $ 43.46M | 68.4% |
| 9/30/2023 | $ 106.21M | $ 53.38M | 50.25% |
| 6/30/2023 | $ 119.25M | $ 62.74M | 52.61% |
| 3/31/2023 | $ 136.87M | $ 70.39M | 51.43% |
Key Performance Insights, Last 5 Years
- FATE THERAPEUTICS INC's latest trailing twelve months (TTM) SB Comp % stands at 144.9%.
- Over the past 5 years, FATE THERAPEUTICS INC's average SB Comp % has been 176.63%.
- The median SB Comp % for FATE THERAPEUTICS INC during this period was 97.59%
- FATE THERAPEUTICS INC reached its highest SB Comp % over the past 5 years at 670.84%.
- The lowest SB Comp % recorded by FATE THERAPEUTICS INC in the same timeframe 50.25%
FATE THERAPEUTICS INC's SB Comp % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
SB Comp % Benchmarks
Similar metrics to SB Comp %:
- Stock Based Compensation - [Cash Flow Statement] Stock Based Compensation, also called Share Based Compensation or Equity Compensation, is a method of paying directors, executives and employees with equity in the business. As non-cash expense, this element is added back when calculating net cash generated by operating activities [NCFO].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation and Amortization Margin - [Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
Definition of Stock Based Compensation Margin
[Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].SB Comp. / Revenues
(=) SB Comp % SB Comp % for FATE THERAPEUTICS INC is calculated as follows: SB Comp. [ $ 26.57M ] / Revenues [ $ 18.34M ]
(=) SB Comp % [ 144.9% ] FATE - Stock Based Compensation Margin, Last 5 years
50.25%
Minimum
Sep 30, 2023
670.84%
Maximum
Mar 31, 2024
176.63%
Average
97.59%
Median
SB Comp % Benchmark AnalysisMarket
The chart above depicts the distribution of SB Comp % for companies in the Total Stock Market. The average SB Comp % of the companies is 1.72% with a standard deviation of 1.9%.
The following table provides additional summary stats:
SB Comp % in the Market:
| filtered constituents | 2.98K |
|---|---|
| min | -3.97% |
| max | 8.43% |
| average | 1.72% |
| median | 1.04% |
| std | 1.9% |